Search research articles
Contact Us
Filters
Showing results (11-20 of 226) with videos related to
Page
of 23
Sort By:
Drug Metabolism Reviews
|
May 9, 2008
Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)
Ulrike Gradhand, Richard B Kim
Gastroenterology
|
April 15, 2022
Failure to Achieve Target Drug Concentrations During Induction and Not HLADQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease: Is HLADQA1∗05 Gone Before It's Here?
Aze Wilson, Richard B Kim
British Journal of Clinical Pharmacology
|
November 11, 2022
Implementation of pharmacogenomics: Where are we now?
Samantha Medwid, Richard B Kim
Annual Review of Pharmacology and Toxicology
|
January 28, 2004
Transporters and renal drug elimination
Wooin Lee, Richard B Kim
Alimentary Pharmacology & Therapeutics
|
April 8, 2021
Letter: genetic variation in the HLA-DQA1*05 allele predicts tumour necrosis factor-α antagonist immunogenicity - does location matter?
Aze Wilson, Richard B Kim
Epileptic Disorders : International Epilepsy Journal with Videotape
|
March 29, 2006
Uncommon, exceptional and atypical: a case of frontal lobe epilepsy due to cortical dysplasia
Arthur C Grant, Richard B Kim
European Journal of Clinical Pharmacology
|
September 4, 2009
Blood-brain barrier transporters and response to CNS-active drugs
Bradley L Urquhart, Richard B Kim
Advanced Drug Delivery Reviews
|
October 31, 2002
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
Rommel G Tirona, Richard B Kim
Clinical Pharmacology and Therapeutics
|
July 9, 2005
St John's wort-associated drug interactions: short-term inhibition and long-term induction?
Hong-Guang Xie, Richard B Kim
Journal of Pharmaceutical Sciences
|
April 29, 2005
Nuclear receptors and drug disposition gene regulation
Rommel G Tirona, Richard B Kim
Page
of 23
Search research articles
Search
Showing results (11-20 of 226) with videos related to
Sort By:
Page
of 23
Drug Metabolism Reviews
|
May 9, 2008
Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)
Ulrike Gradhand, Richard B Kim
Gastroenterology
|
April 15, 2022
Failure to Achieve Target Drug Concentrations During Induction and Not HLADQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease: Is HLADQA1∗05 Gone Before It's Here?
Aze Wilson, Richard B Kim
British Journal of Clinical Pharmacology
|
November 11, 2022
Implementation of pharmacogenomics: Where are we now?
Samantha Medwid, Richard B Kim
Annual Review of Pharmacology and Toxicology
|
January 28, 2004
Transporters and renal drug elimination
Wooin Lee, Richard B Kim
Alimentary Pharmacology & Therapeutics
|
April 8, 2021
Letter: genetic variation in the HLA-DQA1*05 allele predicts tumour necrosis factor-α antagonist immunogenicity - does location matter?
Aze Wilson, Richard B Kim
Epileptic Disorders : International Epilepsy Journal with Videotape
|
March 29, 2006
Uncommon, exceptional and atypical: a case of frontal lobe epilepsy due to cortical dysplasia
Arthur C Grant, Richard B Kim
European Journal of Clinical Pharmacology
|
September 4, 2009
Blood-brain barrier transporters and response to CNS-active drugs
Bradley L Urquhart, Richard B Kim
Advanced Drug Delivery Reviews
|
October 31, 2002
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
Rommel G Tirona, Richard B Kim
Clinical Pharmacology and Therapeutics
|
July 9, 2005
St John's wort-associated drug interactions: short-term inhibition and long-term induction?
Hong-Guang Xie, Richard B Kim
Journal of Pharmaceutical Sciences
|
April 29, 2005
Nuclear receptors and drug disposition gene regulation
Rommel G Tirona, Richard B Kim
Page
of 23